Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-20-002374
Filing Date
2020-08-12
Accepted
2020-08-12 14:32:06
Documents
45
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk2024775.htm 10-Q 574307
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 8237
3 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4657
  Complete submission text file 0001178913-20-002374.txt   2433345

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT atms-20200630.xml EX-101.INS 473348
5 XBRL TAXONOMY EXTENSION SCHEMA atms-20200630.xsd EX-101.SCH 27090
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20200630_cal.xml EX-101.CAL 24141
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20200630_def.xml EX-101.DEF 75036
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20200630_lab.xml EX-101.LAB 165288
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20200630_pre.xml EX-101.PRE 128523
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24431 | Film No.: 201095143
SIC: 2890 Miscellaneous Chemical Products